Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure-Guided Design of ISOX-DUAL-Based Degraders Targeting BRD4 and CBP/EP300: A Case of Degrader Collapse. | J Med Chem | 2025 | 40244695 | PubTator, text mining | PubMed |
| Rational Design of PROTAC Linkers Featuring Ferrocene as a Molecular Hinge to Enable Dynamic Conformational Changes. | J Am Chem Soc | 2025 | 40208910 | PubTator, text mining | PubMed |
| Thalidomide-induced limb malformations: an update and reevaluation. | Arch Toxicol | 2025 | 40198353 | PubTator, text mining | PubMed |
| A method to identify small molecule/protein pairs susceptible to protein ubiquitination by the CRBN E3 ligase. | Chem Sci | 2025 | 40191122 | PubTator, text mining | PubMed |
| Advances in Personalized Treatment and Prognostic Factors of Follicular Lymphoma. | Curr Treat Options Oncol | 2025 | 40172809 | PubTator, text mining | PubMed |
| Probing the E3 Ligase Adapter Cereblon with Chemical Biology. | Acc Chem Res | 2025 | 40167161 | PubTator, text mining | PubMed |
| Development of C646-Based Proteolysis Targeting Chimeras Degraders of the Lysine Acetyltransferases CBP and p300. | ChemMedChem | 2025 | 40165709 | PubTator, text mining | PubMed |
| Structure-guided design of a truncated heterobivalent chemical probe degrader of IRE1α. | RSC Med Chem | 2025 | 40151563 | PubTator, text mining | PubMed |
| Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy. | Expert Opin Ther Targets | 2025 | 40122131 | PubTator, text mining | PubMed |
| Silica-based EGFR-degrading nano-PROTACs for efficient therapy of non-small cell lung cancer. | Eur J Pharm Biopharm | 2025 | 40113047 | PubTator, text mining | PubMed |
| Development of Ethyl-Hydrazide-Based Selective Histone Deacetylase 6 (HDAC6) PROTACs. | ACS Med Chem Lett | 2025 | 40104802 | PubTator, text mining | PubMed |
| Diversity Synthesis Using Glutarimides as Rhodium Carbene Precursors in Enantioselective C-H Functionalization and Cyclopropanation. | J Am Chem Soc | 2025 | 40100075 | PubTator, text mining | PubMed |
| Monoselective Histone Deacetylase 6 PROTAC Degrader Shows In Vivo Tractability. | J Med Chem | 2025 | 40063353 | PubTator, text mining | PubMed |
| Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design. | ACS Omega | 2025 | 40028145 | PubTator, text mining | PubMed |
| Responsiveness of systemic lupus erythematosus subjects to iberdomide based on molecular endotypes. | Ann Rheum Dis | 2025 | 40021405 | PubTator, text mining | PubMed |
| Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider. | Regul Toxicol Pharmacol | 2025 | 40015443 | PubTator, text mining | PubMed |
| PROTAC-induced protein structural dynamics in targeted protein degradation. | Elife | 2025 | 40014381 | PubTator, text mining | PubMed |
| Insights from protein frustration analysis of BRD4-cereblon degrader ternary complexes show separation of strong from weak degraders. | RSC Med Chem | 2025 | 40012705 | PubTator, text mining | PubMed |
| Discovery of a Novel CRBN-Recruiting cGAS PROTAC Degrader for the Treatment of Ulcerative Colitis. | J Med Chem | 2025 | 40012371 | PubTator, text mining | PubMed |
| New strategies to enhance the efficiency and precision of drug discovery. | Front Pharmacol | 2025 | 40008135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=15